Learn

This is a summary of the 25th Asia-Pacific Prostate Cancer 2025 Conference Review which was held in Sydney last month.

Selection and review of the research has been carried out independently by Associate Professor Matthew Roberts, a Urologist from Queensland.

Details

In this edition we feature:

• 177Lu-rosopatamab tetraxetan for mCRPC
• Electroacupuncture for erectile dysfunction after RALP
• RARP in patients aged ≥80 years
• Artificial intelligence and decision-making on short-term ADT
• High-dose vitamin D supplementation and prostate cancer progression
• Urology nurse practitioner role including a prostate biopsy service
• RADA16 self-assembling peptide for refractory haematuria from radiation cystitis
• The expanding role of clinical pharmacists in prostate cancer care
• Focal laser ablation with ProFocal in localised prostate cancer
• Disparities in post-radiotherapy anorectal and urinary adverse effects.

To access this publication please click ‘Enrol Now’ and you’ll be directed to  the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.